Ethics

Magazine

Field Trip Announces “World’s First” Virtual Psychedelic Therapy, But Forgets To Mention They Aren’t the First and No Psychedelics Are Involved

Field Trip Ventures leads the charge to use “psychedelic” as a marketing buzzword for any kind of niche therapy.

Magazine

Bicycle Day 2020 Was Truly Historic, But Not for the Reasons You Think

Jamon A. Rahn, CEO of psychedelic pharmaceutical startup MindMed, offered a glimpse of the future of psychedelic science, including proprietary data and hints of an “LSD neutralizer.”

Magazine

How psychedelic clinical trials are being affected by coronavirus

Almost all clinical psychedelic drug research is being affected in some way or another by COVID-19. But, response measures vary from one organization to the next.

Magazine

Amidst Pandemic, Psychedelic Investor Christian Angermayer Can’t Imagine Life Beyond Capitalism

As the coronavirus pandemic rages on, Christian Angermayer, the world’s largest psychedelic pharmaceutical investor and founder of ATAI Life Sciences, calls to sacrifice public health for the sake of “the economy.”

Magazine

“Flattening The Curve is Complete BS”: Pandemic Advice From Psychedelic Investor Christian Angermayer

In response to the coronavirus pandemic, Christian Angermayer—the world’s largest psychedelic pharmaceutical investor and founder of ATAI Life Sciences—dismisses medical experts in his desperation to reboot the economy.

Magazine

Dear Psychedelic Researchers

The coronavirus has made it clear that psychedelic medicalization will not revolutionize mental healthcare without systemic socioeconomic change.

Magazine

Ayahuasca Healings’ Trinity de Guzman calls coronavirus “a necessary purge”

“The Corona Virus is a necessary purge of what is no longer in resonance,” Trinity de Guzman wrote in a recent email to his followers.

Magazine

Native American Churches Request that Peyote Not Be Included in Decriminalization Initiatives

A long-fought battle for access to peyote, and a dwindling population in the United States has led Native American Church members and peyote conservationists to request that peyote be left out of decriminalization efforts.

Magazine

Calm Down. What’s the Worst Thing That the Wellness Industry Could Do to Psychedelics?

As technology and psychedelics turn to mental health, we’ll likely see a future where we are treated based on our digital biomarkers, and sold mental health services based on the personal data we surrender.

Magazine

“Making psychedelics boring again”— Unless you’re a privileged psychedelic executive, of course

The new leaders of the psychedelic medicalization industry seem to see themselves as above their own self-proposed rules.

Magazine

Never Forget: Before There Was A Mush Rush, There Was A Plea For Decency

Many predicted an ethical storm brewing in the lead-up to the explosion of for-profit interest in psychedelic pharmaceuticals. But, were their efforts to mitigate the damage enough to make a difference?

Magazine

A Statement Regarding “The Emergence of a New Market: Psychedelic Science Conferences”

Our statement on a recent Chacruna article by Dr. Bia Labate.